ArticleDiscover oncology2025

Identification of metabolic biomarkers and therapeutic targets in the thymoma-associated myasthenia gravis treated with methylprednisolone.

Shanshan Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.